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ASTHMA IN A FOUR GENERATION CHINESE FAMILY 
N. Zamel, P.A. McClean, S. Zhang, K. Gan, J. Zhang, Y. Zhou, A.S. 
Slutsky and The University of Toronto Genetics of Asthma Research 
Group. Department of Medicine, University of Toronto, Toronto, Can­
ad a .
A Chinese family, comprising 118 members spanning 4 generations, were 
studied to document a reported high asthma prevalence for the purpose of 
genetic linkage analysis (GLA). Assessment included medical history 
(n=118), allergen skin tests (n=107), airway responsiveness (AR) by 
methacholine challenge (MCh, n=93) or bronchodilator response (BDR, 
n=9) to 400p.g salbutamol, and venous blood samples for total IgE (n=49) 
and GLA (N=95). Ages ranged from 5-68 years. Of those with complete 
data (n=!02), 31% reported a history of asthma (Hx+), 37% demonstrated 
increased responsiveness (AR+); PC20 <8mg/ml (n=38), or BDR £15% 
(n=2), and 26% were atopic. Definitive asthma (Hx+ combined with AR+) 
was present in 17% and partial evidence of asthma (Hx+ or AR+) in 31%. 
Spouses (n-26) were also tested as controls, age range 23-66 years. 12% 
reported a Hx+, 31% AR+, and 16% were atopic, Only 1 control subject 
was asthmatic as defined. Proportions of Hx+, AR+ and atopy in family 
members were not significantly different from controls. However, 54% of 
control subjects were smokers vs 25% of the family members (p<.G5); pack 
year history was also greater (31,7+30.6 vs 15.8±15.2; pc.05). When 
smokers were removed from the analysis, family members were more respon­
sive than the contTo}st AR+ 39% vs 8% (pc.05), Atopy was equally preva­
lent in all groups, however, IgE levels in the asthmatics (619±455 lU/ml; 
n=8) and those with partial evidence of asthma (613±444; n=ll) were sig­
nificantly higher than those with no evidence of asthma (377±306; n=25). 
IgE levels in family members with no evidence of asthma were not signifi­
cantly different from controls (283+288; n=12). As with the Tristan da - 
Cunha population we reported previously (AJRCCM 1994; 149:AIQ51), 
the high prevalence of asthma in this family markedly improves the chances 
o f successfully isolating the genes predisposing to this disease.
Supported by a grant from the National Sanitarium Association.
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IMPORTANCE OF LOCI ON CHROMOSOME 5q IN ALLERGY AND 
ASTHMA
C.I.M. Panhuysen1’2 , D.A. Meyers3, R.C. Levitt3, P.J. W h i n g 2, K.J. 
H olroyd , G.H. Kocter , D.S. Postma . E.R. Bleecker . University 
Hospital, Groningen, The Netherlands, Univ. of Maryland School of 
Medicine, Baltimore, MD, The Johns Hopkins Univ. School of Medi­
cine, Baltimore, MD, USA.
Genetic susceptibility and environmental exposures are important in the 
pathogenesis of asthma. Allergic status and bronchial hyperresponsiveness 
(BHR) are related to its development and progression. 92 families (536 
individuals) were ascertained through an asthmatic proband, were character­
ized clinically, and DNA was obtained for linkage studies. There was a 
close relationship between serum IgE and BHR (PC20 FEV 1 ^ 3 2  mg hista­
mine) with 57% of 58 offspring with IgE > 315IU showing hyperrespon- 
siveness. IgE (Genomics 1994; 23(2): 464-470) and BHR were linked to 
DNA markers on chromosome 5q.
Serum Total IgE BHR
LOD Score Sib-pair Sib-pair /
TL-9 0.58 0.05 0.14
D5S 393 1.14 0.11 0.04
D5S 658 1.05 0.04 0.03
D5S 436 3.63 0.0008 0.009
D5S 470 0.76 0.02 0.10
Using an algorithm based on BHR, asthma symptoms, smoking status, 
airway obstruction and reversibility to diagnose asthma, we found linkage 
to this same chromosomal region for asthma (LOD Score 3,64). Thus, IgE, 
BHR and asthma appear to be related genetically to 5q, a chromosome with a 
number of Important candidate loci (IL-3, IL-4, IL-5, IL-9, IL-12, IL-13, 
GMCSF and the beta-adrenergic receptor). Fine mapping of this area will 
provide important information about the pathogenesis of asthma and allergy.
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TESTING FOR BRONCHIAL RESPONSIVENESS IN A GENERAL 
POPULATION: PROVOCATION OR ASSESS THE PEAK- 
FLOW VARIABILITY?
J.J. den Otter, G. Reijnen, R.P. Akkermans, H.T.M. Folgering*, C.P. van 
Schayck, C. van Weel. Nijmegen University, Dept, of general practice 
and ^pulmonology, Nijmegen, the Netherlands.
Introduction. Bronchial hyperresponsiveness (BHR) is one of the main 
features of asthma. To test the presence of BHR PC20 is normally assessed. 
In epidemiological studies BHR is frequently expressed as percentage of 
peakflow variation (APEF).
Rationale. In this study we try to find out whether BHR expressed as APEF 
is interchangeable with PC20 histamine in the general population.
Methods. 384 Subjects, without a previous diagnosis of asthma/COPD 
from the general population performed 3 weeks home monitoring with a 
peakflowmeter twice daily. Afterwards PC20 was assessed. Questionnaire 
based diagnosis was; 52 asthma, 146 COPD, 186 no diagnosis. APEF was 
calculated as [max-minAnax] *100% and correlated (Spearman) with PC20- 
Results. Correlation between APEF and PC20 was low 
(r=-0.23). For diagnosis asthma the strongest correlation (r=0.39) was 
found. Using PC20 as a golden standard a APEF> 15% has a positive 
predicting value of 54% only. 50 Subjects had a APEF £15% for 21 day 
and PC20 of 32 mg/ml. 100 subjects had a PC20 -  8 mg/mi and not once a 
APEF£ 15%.
Conclusions. APEF and PC20 are measuring different aspects of BHR. As a 
criterion for BHR a APEF of 15% is not suitable.
Funding, This research is funded by the Dutch Asthma Foundation, Dutch 
Organisation for Scientific research & Glaxo Ltd.
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NITRIC OXIDE-SYNTHASE INHIBITION CAUSES AIRWAY RES­
PONSIVENESS TO INHALED BRADYKININ IN NORMAL SUBJECTS 
F,L,M. Ricciardolo, P. Geppetti*, A. Mistretta, J.A. Nadel*, M.A. 
Sapieirza, S, Bellofiore, G.U. Di M aria. Inst, of Respiratory Disease, 
University of Catania, Italy. *Cardiovascular Research Institute, Uni­
versity of California San Francisco, CA, USA.
Inhaled bradykinin (BK) causes a dose-dependent bronchoconstriction in 
asthmatics but not in normal subjects (Fuller, R.W. et ai. Am. Rev. Respir. 
Dis, 1987; 135: 176-180). We have recently shown that bronchoconstric- 
tion induced by BK is reduced by the release of nitric oxide (NO) in guinea 
pigs (Ricciardolo, F.L.M. et al. Br. J. Pharmacol. 1994; 113: 1 147-1152). 
To determine the role of endogenous NO on airway response to BK ip 
humans, we examined the effect of the NO-synthase inhibitor N - 
monomethyl-L-arginine (L-NMMA) or its inactive enantiomer D-NMMA 
(placebo) on airway response to BK in 5 normal subjects (4 MVl F, 18-35 
yrs; FEVj >85%pred). Subjects were studied on two study days according 
to a double-blind placebo-controlled cross-over design. Airway response 
was assessed by measuring FEVj and airflow at 30 percent of vital capacity 
from volume standardized partial expiratory flow-volume curves (V30p). 
After baseline measurements subjects inhaled an aerosol of either L-NMMA 
or D-NMMA (1 mg in 5 ml). After 5 min, saline and doubling concentra­
tions of BK (1.03 to 528.3 \imo\FL) were inhaled until either FEVj fell by at 
least 20% of the postsaline value or the highest BK concentration was 
reached. We also quantified the effect of L-NMMA or D-NMMA on the 
perception of retrosternal discomfort induced by BK by using a Visual 
Analogue Scale. L-NMMA potentiated the airway response to BK. In all 
subjects a measurable PD40V3Qp to BK was obtained only after L-NMMA 
pretreatment. The maximal percent fall in V30p to the highest BK concentra­
tion was 26,1 ±1.7 (Mean±S,E.M.) and 52.1 ±3 ,6 (p<0.01) after D-NMMA 
and L-NMMA, respectively. 'Hie maximal percent fall in FEVj at the highest 
BK concentration was 8.0±1.7 and 17.7±3.8 (p<0.05) after D-NMMA and 
L-NMMA, respectively. The lowest BK concentration causing a detectable 
retrosternal discomfort decreased from 97.7 to 13.8 nmol/L (Geometric Mean, 
p<0.05) after l.-NMMA. These results provide indirect evidence that NO is 
released within the airway upon BK inhalation, and indicate that released 
NO modulates airway responsiveness to inhaled BK in normal subjects. 
Supported by the National Research Council of Italy, Grant 
No.94.02288.CT04.
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